C56 Malignant neoplasm of ovary.
Diagnosed in March 2010.
Ovarian carcinoma G2 stage IIIA, metastases in peritoneum, in the lymph nodes of the abdomen and pelvis, tumor mass in the pelvis, carcinomatosis of the upper abdominal floor (metastases found in 2012, 2015 and 2020).
Surgeries, chemotherapies, radiation therapy.
Most women diagnosed with stage III ovarian cancer have a five-year survival rate of approximately 39%.
Autologous DCV and CIK (5 doses) over a period of 8 months. Immunotherapy was commenced in 2020.
Patient is alive, working, traveling, having ongoing chemotherapy.